Cargando…
Intralesional Administration of Human Recombinant Epidermal Growth Factor Improves Healing and Reduces Amputations in Patients with Severe Diabetic Foot Ulcers
Autor principal: | Garcia Herrera, Aristides L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681321/ https://www.ncbi.nlm.nih.gov/pubmed/29158856 http://dx.doi.org/10.1016/j.curtheres.2017.03.004 |
Ejemplares similares
-
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers
por: Yera-Alos, Isis B, et al.
Publicado: (2013) -
Curative Metatarsal Bone Surgery Combined with Intralesional Administration of Recombinant Human Epidermal Growth Factor in Diabetic Neuropathic Ulceration of the Forefoot: A Prospective, Open, Uncontrolled, Nonrandomized, Observational Study
por: Garcia Herrera, Aristides L., et al.
Publicado: (2017) -
Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey
por: Ertugrul, Bulent M., et al.
Publicado: (2015) -
307 Machine learning identification of diabetic foot ulcer severity to reduce amputation risk
por: Flores, Mario, et al.
Publicado: (2023) -
Diabetic Foot Ulcer: Amputation on Request?
por: Collier, Andrew, et al.
Publicado: (2011)